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I. INTRODUCTION

A. Malondialdehyde (MDA)
MDA (1,3- propanedial) is a three carbon dialdehyde shown to be produced
in significant quantities both in vitro and in vivo.l It was first detected as an end-product
of lipid peroxidation, oxidation of unsaturated fatty acids2 (Figure 1). MDA is also pro
duced enzymatically as a side product of prostaglandin biosynthesis. Prostaglandins are
synthesized in vivo by the oxidative cyclization of polyunsaturated fatty acid.3,4 The cy
clic peroxide (PGH2), derived from arachidonic acid, is the key intermediate which
degrades to MDA by two different prostaglandin synthases, thromboxane synthase5 and
prostacyclin synthase6. Thromboxane synthase generates one molecule of MDA for
every prostaglandin, thromboxane A2, formed (Figure 2).
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Figure 1. Non-enzymatic formation of MDA
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Figure 2. Enzymatic formation of MDA via thromboxane synthase

Chemical modifications of nucleosides followed by replication of the muta
tional event are believed to initiate carcinogenesis. MDA has been reported as a carcin
ogen7, a mutagen8 and as being toxic7 9. Its mutagenicity has been well characterized
both in bacterial10 and mammalian cells.11 Because of its genotoxicity, mutagenicity,
and reaction with nucleic acid bases12, MDA has sparked a great deal of interest in its
potential carcinogenicity.
Among structurally-related compounds, MDA is unique in that it produces
frameshift mutations whereas the others such as methyl glyoxal and acrolein, induce
base-pair substitutions.13 MDA forms several different adducts with deoxyribonucleo-
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sides but it is not certain which adduct causes the frameshift mutations (Figure 3).

Dimer MDA Adduct

Figure 3. Structures of MDA adducts to guanosine, adenosine and cytosine

The adducts can be divided into two main categories; monomer and polymer.
Monomer adducts are formed from a single molecule of MDA, while polymer adducts

4
are formed from polymers of MDA. MDA polymerizes due to its unique ability to exist
as an enolate ion at physiological pH (pKa = 4.46 at 25°C12). The enolate ion serves
both as an electrophile (elec) and a nucleophile (nuc) which readily condense to form
dimers, trimers, and other polymers (refer to Figure 4).

O nuc

NaOH
pKa4.46
Enolate ion
MDA

P-Hydroxy acrolein
MDA

P-Hydroxy acrolein

dimer

trimer

Figure 4. MDA dimer and trimer formation

Ideally, a single adduct on a replicating genome could simulate the in vivo pro
cess by which MDA mutagenesis would occur. With recent advances in oligonucleotide
chemistry and gene splicing, techniques have been developed which construct biologi
cally active genomes with individual DNA adducts at defined sites. This technique is

5
known as site-specific mutagenesis.
The most efficient method for constructing a singly-modified genome utilizes a
gapped heteroduplex, an approach developed by Romano and coworkers14. The gap in
the genome provides the sequence into which a singly adducted complementary oligonu
cleotide is ligated (refer to Figure 5).

Restriction Digest
Isolate large fragment
Denaturation

Singly Adducted
Complementary
Oligonucleotide X
3'----- 1------5’

Singly^dductec
Genome

Renaturation

T4 DNA Ligase
Dialyse
Transform

Figure 5. M13 gapped heteroduplex approach to site-specific mutagenesis

This study involves the synthesis of a small oligonucleotide with a single MDA
derived adduct at a specific site. Once constructed the nucleotide could then be inserted
into the gapped heteroduplex15 for site-specific mutagenesis studies. From this tech
nique, many questions dealing with the mechanism of mutagenesis could be answered:
Of the numerous MDA adducts which adduct causes frameshift mutations? Is a specific
site on the genome important for mutations?
The adduct of interest was rationalized as the 3-(3-D-er7f/zA-0-pentofuranosylpyrimido[l, 2-a]purin-10(3H)-one (PyP in Figure 3) adduct because of the following ob
servations: 1. (3-substituted acroleins with good leaving groups cause frameshift muta
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tions and are thus believed to have a similar mechanism of adduct formation as MDA16;
2. Acridine dyes, planar aromatic molecules, which are very similar in structure to PyP,
also cause frameshift mutations. 3. Of the four bases in DNA, 2’-Deoxyguanosine is
the most reactive towards MDA; and 4. The adducts found in vitro formed from dimers
and trimers of MDA do not seem plausible for an in vivo study since MDA is very reac
tive.
Constructing the PyP oligonucleotide proposes many synthetic challenges. MDA
adducts to deoxyguanosine are very unstable. They are sensitive to both acidic and
basic conditions. MDA in solution pH > 5 is in its ionic form (pKa = 4.46 at 25°C)17.
Once in the enolate form as (3-hydroxy acrolein, MDA can form dimers and trimers
(Figure 4) to result in additional adduct formation. (Refer to Figure 3 for adducts of
dimer18 and trimer 19 MDA). Yields for PyP-dR are reportably poor, 1.86%.12 As a re
sult of the numerous problems mentioned with MDA, 7-Me-PyP appears a good candi
date to study. a-Me-MDA (used to form the 7-Me-PyP), unlike MDA, does not form
polymers (dimers and trimers). The structure of 7-Me-PyP is very similar to PyP and
therefore appears a viable substitution for PyP (Figure 6).

O

O

7-Me-PyP
Figure 6. MDA adduct PyP structural comparison with 7-Me-PyP
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B. T4-RNA Ligase
The construction of the oligonucleotide with the site specific adduct wasce ac
complished enzymatically by a method developed by Brennan and Gumport20 utilizing
T4-RNA ligase. The technique is especially useful for the synthesis of oligonucleotides
with base labile adducts, such as PyP or 7-Me-PyP, since the reaction is carried out in a
physiological pH. The uniqueness of the enzyme, T4-RNA ligase, is its low selectivity
which enables it to ligate DNA and adducted DNA as well as RNA.21
T4-RNA ligase catalyzes the ligation of a donor, 5’-phosphate to an acceptor,
3’-OH. The acceptor must be at least 3 residues in length. The donor can be as small as
one nucleoside, preferably 5’, 3’-bisphosphorylated. The 3’-phosphate on the donor in
hibits the ligation from continuing and prevents multiple ligations of the donor. The
3’-OH on the acceptor molecule is required for ligation.22 Shown below is a simple
equation for the ligation of the deoxyribonucleotide substrates employed.

dCpdGpdC
(acceptor)

+

pdG*p

T4-RNA Ligase

dCpdGpdCpdG*p

(donor)

The mechanism of T4-RNA ligation21 appears analogous to DNA ligation.23
Two key intermediates are involved in the ligation process. Both are covalent complex
es and have been isolated; the adenylylated enzyme24 and the transfer of the adenyl
group of the enzyme to the 5’-phosphate donor to form an ado-5’diphosphate-5’oligonucleotide.25’26 The mechanism is illustrated in Figure 7 with the substrates of
interest.
The substrates employed are the adduct as mentioned, 7-Me-PyP-dR with
phosphates in the 5’ and 3’ positions, and the trimer, dCpdGpdC. dCpdGpdC was

selected due to the occurrence of frameshift mutations in Salmonella typhimuriunm
/z/sD3052, “GC”-rich regions.27 With the use of these substrates an adducted
oligonucleotide, dCpdGpdCpdeGp, can be utilized for further studies in site-specific
mutagenesis.
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Figure 7. Mechanism of T4-RNA ligation, E = T4-RNA Ligase, G* = Ethenoguanine
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II. EXPERIMENTAL

A. Materials
Benzoyl chloride and crotonaldehyde were purchased from Aldrich. All HPLC
grade solvents were obtained from American Scientific. 2-Methyl-1, 1, 3, 3- tetraethoxy
propane was a gift from K. Stone, Wayne State University, Detroit. 3’, 5’-Bisphosphoryl-2’-deoxyguanosine (Na+) was purchased from Pharmacia LKB. Adenylate ki
nase (myokinase grade V, pig muscle dialyzed in 50 mM HEPES-NaOH, 5,000
units/ml), bovine serum albumin, creatine phosphokinase (type 1 rabbit muscle, 1750
units/ml), dithiothreitol, HEPES-NaOH, hexamine cobalt (III) chloride, phosphocreatine, pyrophosphoryl chloride (CAUTION: extremely corrosive), spermine, and triethylamine were all purchased from Sigma. Adenosine-5’-triphosphate (Na+) and 2’deoxyguanosine were obtained from United States Biochemical Corp. T4-RNA ligase
was purchased from three different companies with three different specific activities:
Pharmacia (9000 units/ml), Bethesda Research Laboratories (6000 units/ml) and New
England Biolabs (4000 units/ml). All other reagents were reagent grade and purchased
from standard chemical companies.

B. Instrumentation
HPLC was performed on a Varian Vista 5000 LC with a Varian 2050 variable
wavelength absorbance monitor. Fluorescence was monitored by the Kratos
Fluorescence Detector. The columns used were a Beckman Ultrasphere ODS (5|i, CJ8,
4.6 mm x 25 cm) for analytical purposes and an Altex Ultrasphere ODS (5|U, C]8, 10
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mm x 25 cm) which was used for preparatory or large scale purifications All analytical
columns were run at a flow rate of 1 ml/min unless otherwise specified.
]H-NMR (Proton Nuclear Magnetic Resonance) were recorded on a General
Electric QE 300 Fourier transform spectrometer. dCdGdC was synthesized on a
Beckman System 1 plus DNA Synthesizer at the Molecular Biology Center at Wayne
State University.

C. Synthesis
1. a-Methyl Malondialdehyde (a-Me-MDA)28

In a 10 ml round bottom flask, 1.176 g (5.0 mmol) a-Me-TEP, 1 ml 1 M HC1,
and 2.5 ml distilled H90 were combined. The solution was stirred for 1 hr at 70°C.
After cooling, 5 M NaOH was added dropwise to pH 9. The reaction mixture was evap
orated in vacuo and the residue dissolved in 10 ml anhydrous ethanol. The solution was
filtered to remove NaCl and concentrated in vacuo . The crude product was dissolved in
a minimal amount of ethanol and benzene added dropwise to precipitate the sodium salt
of a-Me-MDA. The mixture was stored at 0°C overnight and the white precipitate was
filtered and washed with cold ethanol to yield 0.968 g Na-a-Me-MDA (70%).
!H-NMR (300MHz, D20): 8 (ppm) 1.54 (s, 3H, -CH3), 8.45 (s, 2H, -CHO).2

2. 2’-Deoxy-7-methyl-3-(P-D-pentofuranosyl)-pyrimido [1, 2-a] purine-10-(3H)one (7-Me-PyP-dR).

The procedure was adapted from Stone29 in which Na-a-Me-MDA 0.120 g
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(1.40 mmol) was dissolved in 1 ml distilled H^O and acidified to pH 3.5. a-Me-MDA
was extracted three times with 4 ml of Et20. The ether extracts were combined and
evaporated in vacuo, without heating. 2’-Deoxyguanosine (dG), 50.5 mg (0.189
mmol), was dissolved in 4 ml DMSO in a 10 ml round bottom flask and a few mg
MgS04 added. The reaction was stirred for 24 hr at 50°C then placed on a high vacuum
line (0.3 torr) to remove the DMSO.
The crude product was chromatographed on a Baker C18, reverse phase MPLC
column with 15% CH3CN/H20 at a flow rate of 4 ml/min . Fractions were collected by
monitoring for yellow color and fluorescence. The reaction mixture was separated by
HPLC on an analytical reverse phase C18 column (4 x 250 mm). Three UV-active (254
nm) peaks were resolved with 20 min of H^O followed by a gradient of 0-15%
CH2CN/H20 in 10 min. The first peak eluting at 23.5 min corresponded to starting ma
terial. The second peak eluted at 28.7 min and possessed fluorescence and NMR prop
erties indicative of 7-Me-PyP. The third peak eluted at 32.5 min and possessed spectral
properties characteristic of 7-Me-PyP-dR. The isolated yield was 25%. ]H-NMR
(300MHz, D20): 5 (ppm) 2.4 (s, 3H, -CH3), 2.6 (m, 1H, H2”,), 2.8 (m, 1H, H2’), 3.75
(m, 2H, H5’’5”), 4.2 (dt, 1H, H4’), 4.6 (dt, 1H, H3’), 6.4 (t, 1H, H1’), 8.4 (s, 1H, H2), 8.9
(s, 1H, H6), 9.1 (s, 1H, H8)

3. Bisphosphorylation Attempts on 2’-Deoxyguanosine

In a 5 ml pear-shaped round bottom flask, 7.3 mg dG (27.3 jimol), dried over
P?05 in a vacuum desicator overnight, 3ml dry THF, dry molecular sieves (3A) and a
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stir bar were cooled to -40°C (ethylene glycol/CG2 bath). Pyrophosphoryl chloride, 100
pi (0.73 mmol, p = 1.85 g/ml) was then added (under N2). After 5 hr, the reaction was
cooled to -78°C (acetone/CO?) and quenched with frozen 0.5 M triethylammonium bi
carbonate (TEAB), pH 7.5 then allowed to warm to room temperature.
The sample was evaporated in vacuo, redissolved in MeOH and evaporated in
vacuo again (to remove excess TEAB). The crude product was diluted in 0.1 M TEAB,
pH 7.5, filtered and run on an HPLC. The gradient used was 0-30% 0.1M TEAB pH
7.5/CH^CN in 20 min on a Beckman reverse phase C18 analytical column (4 x 250 mm).
Three major peaks were detected by UV (254 nm) and determined based on purchased
standards (run on the same gradient) to be: 14.2 min, 3’-dGMP; 15.0 min, 5’-dGMP and
at 15.6 min., dG.

4. Synthesis of (3-Benzoyloxy-a-methylacrolein

In a dry 10 ml round bottom flask, 0.253 g (2.3 mmol) Na-a-Me-MDA, dried
over P?Os in a vacuum desicator, was suspended in 6 ml anhydrous THF. Benzoyl
chloride, 0.326 g (2.3 mmol, 0.27 ml) was slowly added with vigorous stirring at
ambient temperature. The mixture stirred for lhr then the solid was filtered off (NaCl).
The filtrate was evaporated in vacuo . The solid was redissolved in ether, washed
quickly with cold sat'd NaHCO^ and once with cold H90, dried with MgS04, and im
mediately filtered. White needles formed in the filtrate. The solid, (3-benzoyloxy-amethylacrolein, was filtered and weighed at 1.2 mg. The filtrate was evaporated in
vacuo and recrystallized in ether/hexane. The second precipitate, was filtered for a total
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yield of 0.2316 g (53%). 'H-NMR (300MHz, CDC13): 5 (ppm) 2.0

(s,

3H,-CH3), 7.6

(m, 2H, m-Ph-H), 7.7 (dd, 1H, p-Ph-H), 8.2 (dd, 2H, o-Ph-H), 8.3 (s, 1H, C=CH), 9.6 (s,
1H, -CHO). The mass spectrum was also indicative of the product containing a molec
ular ion at 190, Ph-GEO+ at 105 and the phenyl cation at 77.

5. Attempted Synthesis of 7-Me-PyP-dR from [3-Benzoyloxy-a-methylacrolein

In a 5 ml pear shaped round bottom flask, dG 31.0 mg (0.116 mmol, dried over
Pn03 in a vacuum desicator) 0.5 ml dry DMSO, a few mg MgS04 and 27.2 mg (3benzoyl-oxy-a-methylacrolein (0.143 mmol) were combined and stirred for 4 days
under N-,. The mixture was then vortexed and filtered to remove the benzoic acid and
MgS04. The solution was placed on the rotary evaporator attached to a high vacuum
pump to remove the DMSO.
A short MPLC column containing Baker reverse phase C18 packing (2.5 x 30
cm) eluted with 15% CH^CN/P^O at a flow rate of 4 ml/min the crude product. A peak
eluted after 45 min which contained the characteristic yellow fluorescence of 7-Me-PyPdR. The peak was collected and subsequently run on a reverse phase C]X Beckman ana
lytical HPLC column (4 x 250 mm), 0-30% CH^CN/O.IM TEA A pH 6.5 in 30 min. A
band at 20 min coeluted with a 7-Me-PyP-dR standard. Unfortunately, 'H-NMR re
vealed mostly TEA and benzoic acid. The product was quantitatively too small to dis
tinguish.

15

6. Attempted Synthesis of 7-Me-PyP-pdRp by (3-Benzoyloxy-a-methylacrolein

3’, 5’-Bisphosphoryl-2’-deoxyguanosine (pdGp, 8.1 mg, 16 (imol) was placed
in a 5 ml pear shaped round bottom flask with 0.5 ml dry DMSO, under N9. (3Benzoyloxy-a-methylacrolein, 24.8 mg, was then added along with a few mg of
MgS04. The reaction stirred at room temperature. After two days, the fluorescence
characteristic of 7-Me-PyP formation was not evident so 3 ml of 0.1 M TEAA, pH 6.5
was added (in case benzoic acid formation was depurinating the starting material). After
six days, the filtered reaction mixture was run on reverse phase C]S analytical HPLC
column (4 x 250 mm), 0-30% CH^CN/0.1 M TEAA pH 6.5 in 30 min. Fluorescence,
indicative of the 7-Me-PyP adducts, (^ex = 342 nm, A,cm = 370 nm), was not detected.

7. Attempted Synthesis of 7-Me-PyP-pdRp from a-Me-MDA

pdGp (20.5 mg, 40 (imol) was placed in a 10 ml round bottom flask with 450
|il DMSO. (The bisphosphate did not dissolve completely). Na+-a-Me-MDA, 150 mg,
was hydrolyzed to the free acid form. The salt was dissolved in 1 ml H90 and the pH
lowered to 4.0. The acid, a-Me-(3-hydroxyacrolein, was then extracted with 3 x 3 ml
ether and the ether extracts were evaporated in vacuo without warming. DMSO (150
Hi) was added to the a-Me-(3-hydroxyacrolein. The a-Me-(3-hydroxyacrolein/DMSO
(50 |il) was added to the pdGp along with a few mg of MgS04. The reaction mixture

d

16

was then heated to 37°C.
After three days, the crude product was run on the HPLC reverse phase CJ8
preparatory column. The gradient used was 0-10% CH^CN/ 0.1M TEAB (pH 7.5) in 30
min. Various peaks were collected and analyzed by 'H-NMR. Peaks at 16.6 and 17.6
min appeared to contain Oxa and PyP yet the 1 H-NMR were not conclusive due to the
low mass.

8. Synthesis of 3’, 5’-Bisphosphoryl-2’-deoxy-l, N - ethenoguanosine (pdeGp)

2, 3-Epoxybutanal was prepared by the method of Wellman and co-workers.30
It was obtained in a 40% yield and its 1 H-NMR corresponded to literature values.31 *HNMR (300MHz, CDC13): 5 (ppm) 1.5 (d, 3H, -CH3), 3.1 (m, 1H, H3), 3.3 (m, 1H, H2),
9.0 (d, 1H, -CHO).
3’, 5’-Bisphosphoryl-2’-deoxyguanosine (10.3 mg, .02 mmoles) was placed in
a 5 ml pear shaped round bottom flask. 2, 3-Epoxybutanal (10 p.1) was added. Distilled
water (2.6 ml) was then added and the pH was raised to 10. The reaction stirred vigor
ously for 3.5 hr at room temperature. Afterwards, the solution was neutralized with 0.1
M HC1, evaporated in vacuo, redissolved in 0.1 M TEAB pH 7.5, filtered and run on an
HPLC. The crude mixture was separated on a Rainin DYNAMAX reverse phase C18
column (21.4 x 250 mm) with a gradient of 0 to 9% CH3CN/0.1M TEAB pH 7.5 in 35
min.
The major peak eluting at 31.2 min appeared to be product, pdeGp, by 'HNMR. The product was reinjected onto the DYNAMAX HPLC reverse phase C]8 col
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umn, collected then tested for purity onaC,8 analytical column. The overall yield of
the reaction was 35% (0.01695 mmoles). The 5H-NMR was indicative of the ethenoguanosine adducts previously cited in literature.32 ’H-NMR (300MHz, D20) 8
(ppm): 2.7 (m, 1H, H2”), 3.0 (m, 1H, H2’), 4.2 (d, 2H, H5 ,5”), 4.5 (m, 1H, H4’), 5.1 (m,
1H, H3’), 6.5 (m, 1H, H1’), 7.4 (d, 1H, H7), 7.6 (d, 1H, H6), 8.4 (s, 1H, H2).

9. Synthesis of dCpdGpdCpdeGp
The T4-RNA ligase reaction procedure was followed from Gumport33 35 in
which the nucleotides (pdeGp, 4 mM,

~12xl0332), oligo (dCpdGpdC, ImM), sper

mine (8 mM), phosphocreatine (40 mM), ATP (0.4 mM), and HCC (10 mM) were dried
under vacuum in a 1.5 ml screw-top Eppendorf plastic tube. Upon completion of dry
ing, the following were added to a total volume of 10 ql: 50 mM HEPES-NaOH (pH
7.9), 10 qg/ml BSA, 20 mM DTT, 5 mM MnCl2, and H20 (nano-pure), myokinase
(-1690 units), phospho-creatine kinase (1750 units) and T^-RNA Ligase(15-50 units).
The reaction tubes were incubated at 17°C for 1-10 days (Heated H20 bath in the cold
room, tubes were submerged to avoid a change in concentration by evaporation or
condensation).
Samples were prepared for the HPLC by first stopping the ligation with EDTA
(9 jLil EDTA for every 1 ql aliquote of reaction mixture) then precipitating the enzyme
with CH3CN/H20 with a total percentage of 50% acetonitrile (e.g. For a 1 ql aliquote of
ligation mixture, 9 ql EDTA, 15 ql H20 and 25 ql CH^CN were added). The Eppendorf
tubes were spun for 5 min to pellet the enzyme. The supernatant was then removed and
placed into a new tube and dried. The residue was redissolved in 50 ql 1100 and
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injected onto the HPLC.
The mixture was separated on a reverse phase CJ8 analytical HPLC column.
The solvent system used was a shallow gradient from 0-12% CH^CN/50 mM TEAB pH
7.3 in 30 min. then a sharp increase from 12-30% CH^CN/50 mM TEAB pH 7.3 in 5
min. The column was washed with 100% CH^CN for 10 min after every injection. For
a typical chromatigraph refer to Figure 8.

Figure 8. UV profile of reverse-phase C18 column separation. Samples were run with a gradient from 0-12% •
CH3CN/5O mM TEAB pH 7.3 in 30 min. A = ATP, B = pdeGp, C = dCpdGpdC, D = dCpdGpdCpdGp
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III. RESULTS

A. Synthesis of 7-Me-PyP-dR

a-Me-MDA was hydrolyzed and combined with 2’-deoxyguanosine to
produce 7-Me-PyP-dR (refer to Figure 9).

Figure 9. Synthesis of 7-Me-PyP-dR

Various conditions were utilized in order to maximize the yield of 7-Me-PyPdR with as little depurination as possible. Two molecules of water are eliminated in the
formation of PyP, therefore materials were included to enhance the removal of water
(e.g. molecular sieves (3A) and MgS04).
Apparently, water was not the only thing trapped in the molecular sieves.
Reactions which contained molecular sieves (3A) yielded less of the 7-Me-PyP-dR, the
desired product, than reactions containing MgS04 (refer to Figure 10). Any reactions
containing the molecular sieves also produced more depurinated product than 7-MePyP-dR (refer to Figure 11). MgS04 seemed to enhance the formation of product before
it depurinated (refer to Figure 12).
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Molecular sieves (3A)

Time (hr)
Figure 10. 7-Me-PyP-dR formation influenced by MgS04 and Molecular sieves (3A). Formation is
denoted by height of fluorescent (\x= 342, ^em= 370) Peaks eluting from C18 analytical HPLC
column.

7-Me-PyP

7-Me-PyP-dR

Time (hr)
Figure 11. Molecular sieves enhanced production of depurinated over deoxyribose, 7-Me-PyP.

22

7-Me-PyP-dR

7-Me-PyP

Time (hr)
Figure 12. MgSO^ enhanced production of 2-’deoxyribose (dR) over depurinated, 7-Me-PyP

A second approach to increasing the product yield was to vary the temperature.
Heat seemed to increase the amount of product, but with the increase in temperature
time became a crucial factor. At 50°C a maximum yield was obtained in one day but
after six hours depurination became faster than product formation (refer to Figure 13).
Concentrating the reactants in DMSO improved the yield of 7-Me-PyP-dR.
The estimated solubility of dG in DMSO was 0.115 g/ml and the estimated solubility of
a-Me-(3-hydroxy acrolein was 0.272 g/ml. The optimal concentrations were found to be
1 mM dG and 10 mM a-Me-(3-hydroxyacrolein.
Maximum yield for 7-Me-PyP-dR was obtained under the following
conditions; MgS04 addition, maintain temperature at 50°C for 6 hr, and highly
concentrated reactants. The yield of 25% was much greater than a previously published
yield of 1.86% for the formation of PyP-dR.12

4
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Figure 13. Time dependent depurination of 7-Me-PyP-dR at 50°C. Fluorescent profiles (Xm= 370,
342 nm)
on C18 Analytical column (flow = 1 ml/min) at a) 2 hr (0-15% CH3CN/H20 from 20-30 min) and b) 72 hr
(0-15% CH3CN/H20 in 20 min). A = 7-Me-PyP, B = 7-Me-PyP-dR.
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B. Attempts at the Synthesis of 7-Me-PyP-pdRp

Three different approaches for the preparation of 7-Me-PyP-pdRp were
pursued. These are as follows:
1. Bisphosphorylation Attempts on 7-Me-PyP-dR.
Barrio, et. al,,36 predicted the bisphosphorylation of dG and 7-Me-PyP-dR by
pyrophosphoryl chloride as shown in the following reaction:
O

Once phosphorylated, pdGp or 7-Me-PyP-pdRp could be used as the substrate for the
T4-RNA ligase reaction. Numerous reactions were run to test this hypothesis.
Initial reactions employed Barrio’s procedure for the bisphosphorylation of
guanosine and 7-Me-PyP-R36 with 7-Me-PyP-dR as starting material (see Experimental
Section). Most experiments, upon addition of pyrophosphoryl chloride, turned instantly
to a brown tar. This was due to incomplete drying of starting material. Of the reactions
that worked, usually only two products were detected, starting material and depurinated
product (14a).
Fearing that the adduct maybe enhancing the depurination, deoxyguanosine
was used as a starting material instead of the 7-Me-PyP-dR. Results were still negative;
deoxyguanosine did not form bisphosphate but depurinated. In order to discover the
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reason for depurination, the pH of the reaction mixture before quenching the reaction
mixture was tested (the mixture contained only the starting materials, dG and pyrophosphoryl chloride). The pH was found to be less than 2. Therefore, it seemed obvious that
it was the low pH that caused the depurination and that this pathway was not a viable ex
tension to form the substrate for the ligase reaction, 7-Me-PyP-pdRp from the 2’-deoxyribose, 7-Me-PyP-R.
Subsequent attempts were made to modify the procedure by using anhydrous
solvents and greater concentrations of buffer. Even the best results did not lead to the
desired bisphosphate product, but only produced the monophosphorylated product (refer
to Figure 14b).
2. Attempted Synthesis of 7-Me-PyP-dR from a-Me-MDA and pdGp.
The procedure followed was similar to the above synthesis of 7-Me-PyP-dR in
which a-Me-MDA was hydrolyzed to its acid form, a-Me-P-hydroxyacrolein, and
added to pdGp in DMSO. Likewise a few milligrams of MgS04 were also added.
Unlike the deoxyribose reaction the temperature was lower with a longer reaction time
(37°C and 3 days) due to the lower stability of the phosphates. Unfortunately, the yields
were too low to get conclusive identification of 7-Me-PyP-pdRp.
3. Attempted Synthesis of 7-Me-PyP-pdRp from P-Benzoyloxy-a-methylacrolein
and pdGp.
Based on the fact that good leaving groups in the P-position of acroleins
enhance the mutagenicity and therefore possible reactivity with nucleotides,
P-Benzoyloxy-a-methylacrolein was used as a starting material to increase the yield of
7-Me-PyP-pdRp. The appearance of the adduct was not evident based on fluorescence

Figure 14. Bisphosphorylation UV profiles from Cl8 Analytical Column (flow = 1 ml/min) with
a) 7-Me-PyP-dR (0-20% CH3CN/O.I M TEAA pH 6.5 in 30 min. Note only starting material, A,
and depurinated, B, were formed) and b) 2’-deoxyguanosine (dG) in which only monophosphorylated
dG was formed (0-30% CH3CN/0.1 M TEAA pH 6.5 in 20 mm. A = 7-Me-PyP, B = 7-Me-PyP-dR
C = monophosphorylated dG, D = dG.
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and in the 'H-NMR, only benzoic acid was distinguishable.

C. Synthesis of pdeGp
A new substrate for the ligase reaction, pdeGp, an adduct similar in structure to
7-Me-PyP-pdRp, was synthesized. The adduct was prepared by adding 2, 3 - epoxybu
tanol to pdGp in the following reaction:

2, 3-Epoxybutanol

Purification of the deoxynucleotide was somewhat more difficult than previously report
ed32 because the phosphorylated adduct did not precipitate from solution as the
unphosphorylated product does. After HPLC separation the 1 H-NMR revealed the
major product to be the desired adduct, pdeGp, in a 35% yield. In the 1 H-NMR, the
C’

C”

sugar protons, H ’

O’

, and H

are shifted downfield indicative of the attached 3’, 5’-

phosphates (refer to Figure 15).

D. T4-RNA Ligase

Several authors have successfully utilized T4-RNA ligase for the formation of
a small adducted oligonucleotide at a specific site.36 20 The mechanism involves the

a
7

10

8

6

4

2

0

PPM

Figure 15. 'H-NMR comparison between a) pdeGp in D2Q and b) dfG in DMSO-d6
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ligation of the donor (pdeGp or G*) to the 3’-OH of the acceptor molecule (dCdGdC) as
shown in Figure 16.

Figure 16. Enzymatic synthesis of an oligodeoxyribonucleotide by
T^-RNA Ligase, R = HO-dCpdG

To determine the extent of successful ligation, every ligation experiment
contained a standard reaction (a separate tube) which contained pdGp as the acceptor
instead of adducted bisphosphate, pdeGp. Initial experiments were designed to
determine if pdeGp was a substrate for the enzyme. These experiments indicated that
pdeGp is a poor substrate. The yield for dCpdGpdCpdeGp appeared close to 1% (refer
to Figure 17). To test if pdeGp was inhibiting the ligase, pdGp was run in the same tube
along with pdeGp. Both ligation products, dCpdGpdCpdGp and dCpdGpdCpdeGp did
appear to be formed (refer to Figure 18). Thus pdeGp was not a complete inhibitor of
the ligase but a competitive substrate with pdGp for ligation.
Even though pdeGp was not completely inhibiting the enzyme, the yields for
the ligation were low and did not run to completion. The pdeGp was repurified on
HPLC to remove any impurities that may be inhibiting the ligation. Triethylamine
impurities were found in the 0.1M TEAB buffer and removed by distilling the TEA over

Figure 17. T4-RNA ligation of a) pdGp and b) pdeGp with dCdGdC
A = dCdGdCdGp, B = dCdGdC, C = dCdGdCdeGp?

D

Cf

Figure 18. T4-RNA Ligation with both pdGp and pdeGp. A = 5'-Adenylated donor?,
B = dCdGdC, C = dCdGdCdGp, D = dCdGdCdeGp?

31

~0.5%C1SO^ onto KOH pellets, redistilling and collecting at 89°C. Buffers were pre
pared just prior to use since storage at 4°C overnight resulted in detectable impurities by
UV and fluorescence spectroscopy. After purification of pdeGp, its yield of ligation to
form dCpdGpdCpdeGp seemed to increase slightly (Figure 19).
Several other attempts were made to increase the yield of the reaction.
Tessier’s modifications3 ' of an added polymer (25% polyethylene glycol, PEG) and low
ATP concentrations were applied to the technique. Twenty-five percent PEG increased
the yield slightly but the ATP modification of removing the regeneration system (phosphocreatine, creatine phosphokinase, and adenylate kinase omitted from reaction mix
ture) didn’t appear to change the yield.
Attempts to scale up the standard reaction (2x and lOx) did not increase
product yield. With an increase of 10 fold, no product was observed. In the 2 fold
experiment, after 2 days, the product reached about 10% then dropped. The addition of
more enzyme appeared to inhibit ligation. The yield for any reaction (either substrate,
pdGp or pdeGp) was below 50% and variable depending on the specific activity of the
enzyme.
T4-RNA ligase purchased from different companies produced very different
yields. Yields directly correlated with the specific activity of the enzyme purchased.
Ligations involving the Pharmacia enzyme (27 units, 9000 units/ ml) gave the best
yields as denoted in reactions with the “standard”, pdGp and d(pA)4. Bethesda
Research labs (BRL, 18 units, 6000 units/ml) had slightly lower yields while Biolabs (12
units, 4000 units/ml) enzyme had a very low yield in comparison (refer to Figure 20).
Although Biolabs ligase gave very poor yields the enzyme was not as sensitive to amine
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impurities as the other ligases, BRL and Pharmcia.

Figure 19. UV profiles (A. = 250) of the formation of dCpdGpdCpdsGp by T4-RNA Ligase on Spherisorb S5
SAX column, 10^40% 1 M KH2P04, 5% MeOH/5% MeOH in 20 min. a) Reaction at time = 0. b) Reaction
after 7 days. Note formation of C at 38 min. A = pdeGp, B = dCpdGpdC, C = dCpdGpdCpdeGp.
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a

b

c

Figure 20. T4-RNA Ligase comparison between a) Biolabs b) BRL and c) Pharmacia,
A - d(pA)4, B = dApdApdApdApdGp (ligation product). Spherisorb S5 SAX column
10-40% 1 M KH2P04, 5% MeOH/ 5% MeOH in 40 min.
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IV. DISCUSSION

Two different strategies were applied to the synthesis of 7-Me-PyP-pdRp, the
T4-RNA ligase donor substrate: Phosphorylating the adduct and modifying the 3’, 5’bisphosphorylated deoxyguanosine. Phosphorylating the adduct would be preferred due
to economic reasons.
Phosphorylation of 7-Me-PyP-dR was proposed as a plausible reaction, be
cause 7-Me-PyP-ribose can be successfully phosphorylated.36 Initially, experiments
were conducted to synthesize 7-Me-PyP-dR because the adduct’s preparation gives few
side products and good yields, and 3’, 5’ -bisphospho-2’-deoxyguanosine is very
expensive ($250/5()mg, Pharmacia). The yield for the synthesis of 7-Me-PyP-dR was
increased greatly over previous literature for PyP-dR from 1.86%12 to 25%. This was
accomplished by the addition of MgS04, the use of a high concentration of reactants,
and by optimizing the temperature and duration such that maximum yield was obtained
with as little depurination as possible.
MgS04 is known to complex or trap water. Molecular sieves (3A), also known
for their ability to trap water, were tested and compared to MgS04 for enhanced
production of 7-Me-PyP-dR. Molecular sieves did not work nearly as well as MgS04
(refer to Figure 10). In fact molecular sieves yield more depurinated product than 7-MePyP-dR (refer to Figure 11). MgS04, on the other hand, produces more 7-Me-PyP-dR
than the depurinated form, 7-Me-PyP (refer to Figure 12). Either entrapment of water
by MgS04 acts as a driving force for the condensation, the elimination of water helps to
prevent depurination, or it is a combination of the two that enables the MgS04 to
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increase the yield of the 7-Me-PyP-dR. Molecular seives do not accomplish this same
phenomena probably because they trap MDA.
In order for 7-Me-PyP-dR to be utilized as substrate for the enzymatic reaction
it had to be phosphorylated. Although Barrio, et. al.36 has proposed bisphosphorylation
of dG and 7-Me-PyP-dR our attempts with their method were futile. The pH for the
reaction was too low thus the product depurinated (refer to Figure 14a). Any attempts to
modify the procedure, such as utilizing solvents or buffers, did not result in the bisphosphorylated but only the monophosphorylated product (refer to Figure 14b).
The approach was then turned towards adducting pdGp. The reaction of MDA
with pdGp yielded virtually no product. Basu16 has shown that increasing the leaving
group ability of a series of acrolein substituted on the (3-carbon increased their
mutagenicity. Therefore (3-benzoyloxyacrolein, a compound with a very good leaving
group on the (3-carbon of acrolein, was used in the attempted synthesis of 7-Me-PyPpdRp. The benzoic acid that formed from the (3-leaving group proved to be more detri
mental to the stability of the purine than beneficial to the yield. Neither starting material
nor product, only benzoic acid, was detected in the ^H-NMR.
Due to the lack of success with PyP, etheno-2’-deoxyguanosine, deG, an
adduct with a very similar structure to the PyP base was employed (Figure 22). pdeGp
was readily obtained by the reaction of pdGp with 2, 3-epoxybutanal with an overall
yield of 35%. The 'H-NMR revealed a downfield shift of the all the sugar protons
except H4 indicating that both phosphates were present (refer to Figure 15a,b). The
ligase acceptor, dCpdGpdC, was readily synthesized on a DNA sequencer and purified
by C-18 analytical HPLC. These substrates were then used for ligation.
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Figure 22. MDA adduct, pd(PyP)p, structure comparison with pdeGp

Many problems arose in the ligation reactions. Not only was the enzyme, T4RNA ligase, difficult to purchase with a high specific activity but a method of detection
had to be developed. Originally the reaction mixture was separated with an ionexchange column (Micropak and Spherisorb S5 SAX) but soon after use the retention
times changed drastically. Without consistent retention times it was difficult to distin
guish product peaks from impurities; results became incomparable. It is uncertain why
column performance was inconsistent; perhaps the EDTA added to chelate the Mg+i'
affected the column. Techniques established by other researchers36 proved infeasible
because the anion exchange columns were unobtainable (Rainin or Phase Sep S5 SAX
column on back-order for 9 months). Using a readily available Beckman C-18
Analytical column and ion-pairing, HPLC separation between substrates and products
was obtained (refer to Figure 8).
The ligase reaction did show some promise. There appears to be product, a
peak at 38 min that increases over time (refer to Figure 19). The pdeGp is obviously not
as good a substrate as the standard, dG. Reactions with the substrates under the same
conditions produce a greater percent ligation of dG than pdeGp (refer to Figure 17). As
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Figure 18 shows, pdeGp does not completely inhibit the ligase and once the amine
impurities were removed the ligation increased (compare Figure 17 with Figure 19).
The substrate ligation not only seemed to be dependent on the purity of the
substrate but also changed for the various enzymes (different suppliers of the T4-RNA
ligase). The enzyme with the highest specific activity, Pharmacia’s, performed ligation
to the greatest extent (refer to Figure 20). The Pharmacia ligase was also more sensitive
to impurities then the other enzyme suppliers, Biolabs and BRL, tested. With any impu
rities present (detected by ]H-NMR), ligation for the Pharmacia enzyme dropped from
about 50% ligation to less then 10% while the Biolabs enzyme only ligated about 3%
but was insensitive to the presence of impurities (results not shown).
Unfortunately, not enough material was produced to enable complete
characterization. Several variations of the method were attempted to improve the mass
and yield of the product, dCpdGpdCpdeGp, (e.g. scaling up the reaction mixture and
adding PEG) yet none were successful. The substrate, pdeGp, is a poor substrate in
comparison to dG with only about 10% ligation compared to almost 50% found for dG.
Often noted in HPLC profiles for the ligation of pdeGp but not the standard,
pdGp, is thought to be AMP-pdeGp (refer to Figure 7 and Figure 18). Perhaps the rea
son pdeGp is a poor substrate is due to this structure. Uhlenbeck and Gumport35 noted
that once the donor is adenylylated, ATP and the enzyme are no longer required for liga
tion to occur. Perhaps the yields can be improved if the adenylated donor, AMP-pdeGp,
could be isolated and reacted with the acceptor, dCpdGpdC. Gumport21 also noted that
base helps to shift the equilibrium from adenylylated donor, AMP-pdeGp, to product.
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pH studies of the reaction could denote optimum pH for maximum yields.

If yields

could be improved such that the identification of the product was evident, the ligation of
dCpdGpdC to pdeGp by T4-RNA ligase would be a useful method.
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Malondiadehyde (MDA) is a known carcinogen and mutagen produced by
lipid peroxidation and prostaglandin synthesis in vivo. MDA is unique from structural
ly related compounds, methyl glyoxal and acrolein, because it produces frameshift muta
tions whereas the latter compounds induce base-pair substitutions. MDA forms several
adducts with deoxyguanosine but it is not certain which one causes the frameshift muta
tions. Ideally, a single adduct on a replicating genome could simulate the in vivo pro
cess by which MDA mutagenesis would occur. This technique is known as site-specific
mutagenesis. The approach of choice for site-specific mutagenesis experiment is the
gapped heteroduplex method which requires the formation of a small oligonucleotide
with an adduct at a defined site. The construction of the oligonucleotide with the site
specific adduct was attempted by ligating an adducted bisphosphate to the oligonucle
otide, dCpdGpdC, with T4-RNA ligase. The synthesis of 3’, 5’-bisphosphoryl-7-

methyl-3-(f3-D-pentofuranosyl)-pyrimido [1, 2-a] purine-10-(3H)-one-2’-deoxyribose
(7-Me-PyP-pdRp) was attempted. Although modification of the synthesis of 7-methyl3-(p-D-pentofuranosyl)-pyrimido [1, 2-a] purine-10-(3H)-one-2’-deoxyribose, the precusor to 7-Me-PyP-pdRp, with MgS04 and minimal concentrations of reactants im
proved the yield to 25%, the bisphosphate could not be formed. An adduct similar in
structure to the MDA adduct was employed. The adduct, formed from 2, 3-epoxybutanal under basic conditions in a 35% yield, was 3’, 5’-bisphosphoryl-l, N -etheno-2’deoxyguanosine.
Substrates, pdeGp and dCpdGpdC, for the T4-RNA ligase were successfully
prepared. Ligation appeared successful, based on UV profiles, except possitive identifi
cation of the oligonucleotide product, dCpdGpdCpdeGp, was not possible due to low
yields. Any modifications to increase the yield such as scale up attempts and polyethyl
ene glycol addition were ineffective.
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